2014
USAID PREDICT: REDUCING PANDEMIC RISK, PROMOTING GLOBAL HEALTHA 2014 archived USAID report proudly states that the agency funded research on "novel bat SARS-like coronaviruses" at the Wuhan Institute of Virology.
These newly identified coronaviruses were found to bind to the human ACE-2 receptor, suggesting the potential for direct transmission from bats to humans.
Similarly, SARS-CoV-2—the virus responsible for COVID-19—exhibited a highly efficient ability to bind to the ACE-2 receptor, significantly enhancing its ability to infect humans.
The USAID report states:
"In China, PREDICT partnered with USAID and set up long-term collaborations with the Wuhan Institute of Virology."
"PREDICT isolated for the first time SARS-like coronaviruses from bats sampled in China, fully characterized the whole genome of two novel bat SARS-like coronaviruses, and demonstrated a bat SARS-like coronavirus with 99.98% sequence homology to SARS coronavirus. The virus was found to bind to the human ACE-2 cell receptor, suggesting that direct transmission to humans from bats is possible."
"PREDICT has found a surprisingly high number of positives of SARS-like coronaviruses in bats sampled in China. Several of these viruses were novel, and some bats tested positive for multiple novel viruses."
"PREDICT investigators also isolated for the first time and characterized the binding receptor from a SARS-like coronavirus from a Chinese horseshoe bat (Rhinolophus sinicus; Ge et al. 2013). Results showed the virus was able to bind to the human ACE-2 cell receptor, suggesting that direct transmission to humans from bats is possible."
Was research on novel bat coronaviruses at the Wuhan Institute of Virology a good use of American taxpayer funds?
https://web.archive.org/web/20240916...s/PBAAF347.pdf




.......................
Precursor research 2013 also funded by USAID & NIH
https://pmc.ncbi.nlm.nih.gov/articles/PMC5389864/
We acknowledge financial support from the State Key Program for Basic Research (2011CB504701 and 2010CB530100), National Natural Science Foundation of China (81290341 and 31321001), Scientific and technological basis special project (2013FY113500), CSIRO OCE Science Leaders Award, National Institute of Allergy and Infectious Diseases (NIAID) award number R01AI079231, a National Institutes of Health (NIH)/National Science Foundation (NSF) ‘Ecology and Evolution of Infectious Diseases’ award from the NIH Fogarty International Center (R01TW005869), an award from the NIH Fogarty International Center supported by International Influenza Funds from the Office of the Secretary of the Department of Health and Human Services (R56TW009502), and United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT. The contents are the responsibility of the authors and do not necessarily reflect the views of NIAID, NIH, NSF, USAID or the United States Government. We thank X. Che from Zhujiang Hospital, Southern Medical University, for providing human SARS patient sera.